|1.||Chen, Daozhong: 1 article (06/2010)|
|2.||Dong, Yi: 1 article (06/2010)|
|3.||Chen, Liangwan: 1 article (06/2010)|
|4.||Liu, Xiaoying: 1 article (06/2010)|
|5.||Yang, Liping: 1 article (06/2010)|
|6.||Zhang, Guican: 1 article (06/2010)|
|7.||Li, Li-huan: 1 article (04/2005)|
|8.||Liu, Rong-guo: 1 article (04/2005)|
|9.||He, Ai-xia: 1 article (04/2005)|
|10.||Wang, Wei-jian: 1 article (04/2005)|
06/01/2010 - "Cardiomyopeptidin for injection may improve the energy metabolism, improve coronary blood flow and cardiac function after the reperfusion, thus protecting immature myocardial against ischemia-reperfusion injury in young rats. "
06/01/2010 - "To investigate the effect of cardiomyopeptidin for injection on energy metabolism in isolated hearts of young rats after ischemia-reperfusion injury. "
06/01/2010 - "[Effect of cardiomyopeptidin for injection on energy metabolism in isolated hearts of young rats after ischemia-reperfusion injury]."
06/01/2010 - "Fifty young healthy SD rats(aged 20 +/- 3 days and weighing 50-70 g) were randomly divided into 5 groups: a normal control group (NC group, n = 10 ): the isolated hearts were stable for 20 min, and then 150 min continuous perfusion; a normal + cardiomyopeptidin group (NCMP group, n = 10): the same as the normal control group, but K-H buffer solution was added with 50 mg/L cardiomyopeptidin, and 3 ischemia-reperfusion injury model groups, including a model control group (n = 10): the isolated rat hearts were perfused with K-H buffer and then arrested with cardioplegic solution; a CMP1 group (n = 10): the ST.Thomas'II cardioplegic solution was added with 100 mg/L cardiomyopeptidin; CMP2 group (n=10): K-H buffer and ST.Thomas'II cardioplegic solution was added with 50 mg/L and 100 mg/L cardiomyopeptidin respectively. "
02/01/2000 - "Cardiomyopeptidin has a preventive effect on myocardium injured by ischemia-reperfusion and this may be related to its reducing the release of myocardial enzyme and anti-lipoperoxidation."
02/01/2000 - "Cardiomyopeptidin could obviously prevent the injury caused by ischemia-reperfusion, reduce the activities of CK and LDH and the content of MDA in a dose-dependent manner. "
02/01/2000 - "To investigate the preventive effect of cardiomyopeptidin of small molecular weight polypeptide on rat hearts injured by ischemia-reperfusion. "
02/01/2000 - "[Preventive effect of cardiomyopeptidin on rat heart injured by ischemia-reperfusion]."
02/01/2000 - "In a rat model injured by ischemia-reperfusion in the heart, observation was made on the influence of cardiomyopeptidin on the activities of creatine kinase (CK) and lactate dehydrogenase(LDH), as well as on the content of MDA in plasma after the preventive drug was used. "
|1.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|2.||Creatine Kinase (Creatine Phosphokinase)